Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

110.17 +1.43 (+1.32%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years ↗

October 11, 2023

This company's fight against a deadly disease could pay off.

Via The Motley Fool

Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health? ↗

October 08, 2023

The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.

Via The Motley Fool

Why Guardant Health Stock Jumped 15% This Week ↗

September 28, 2023

The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.

Via The Motley Fool

Why Guardant Health Stock Popped Again Today ↗

September 28, 2023

Wall Street loves this unprofitable biotech.

Via The Motley Fool

Guardant Health Has 'Underlying Business Strength' Says This Bullish Analyst ↗

September 27, 2023

Shares of Guardant Health Inc (NASDAQ: GH) climbed during the premarket trading session and morning on Wednesday.

Via Benzinga

Analyst Expectations for Guardant Health's Future ↗

September 27, 2023

Via Benzinga

The Latest Analyst Ratings for Guardant Health ↗

August 04, 2023

Via Benzinga

Preview: Guardant Health's Earnings ↗

August 02, 2023

Via Benzinga

Analyst Ratings for Guardant Health ↗

May 26, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023 ↗

September 28, 2023

Via Benzinga

Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

September 26, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 26, 2023 – USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The...

Via FinancialNewsMedia

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023 ↗

September 27, 2023

Via Benzinga

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year ↗

September 21, 2023

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday.

Via Benzinga

Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan

September 06, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations

September 05, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test

September 01, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

August 31, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Host Investor Day on September 7, 2023

August 17, 2023

From Guardant Health, Inc.

Via Business Wire

2 Cathie Wood Stocks to Buy and Hold for 10 Years ↗

August 10, 2023

These companies' growth stories still have plenty of exciting chapters ahead.

Via The Motley Fool

Guardant Health Stock Sees Renewed Technical Strength ↗

August 07, 2023

Guardant Health stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 79 to 85.

Via Investor's Business Daily

Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance

August 03, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research

August 01, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana

July 20, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023

July 12, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

July 05, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark ↗

June 23, 2023

On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before.

Via Investor's Business Daily

Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting

May 31, 2023

From Guardant Health, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2023 ↗

May 26, 2023

Via Benzinga

Guardant Health to Participate in Upcoming June Investor Conferences

May 26, 2023

From Guardant Health, Inc.

Via Business Wire

Guardant Health Shares Move Lower On $350M Public Offering: The Details ↗

May 23, 2023

Guardant Health Inc (NASDAQ: GH) shares are trading lower Tuesday after the company announced an offering.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Guardant Health, Inc. - Common Stock (NQ:GH)

All News about Guardant Health, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today